MedPath

Discharge Education in Diabetic Surgical Patients

Not Applicable
Not yet recruiting
Conditions
To Examine the Effects of Diabetes-based Personalised Discharge Education Given to Diabetic Surgical Patients on Satisfaction
To Examine the Effects of Diabetes-based Personalised Discharge Education Given to Diabetic Surgical Patients on Diabetes Empowerment
Registration Number
NCT06777836
Lead Sponsor
Abant Izzet Baysal University
Brief Summary

In the literature, it is seen that the discharge education given to patients with diabetes is especially focused on the effects of blood glucose control and self-efficacy, and there is no study examining the effects of discharge education on diabetes empowerment with a more general perspective in diabetes patients in surgical processes. In this context, the study was designed to examine the effects of diabetes-based personalised discharge education given to surgical patients on satisfaction and diabetes empowerment.

Detailed Description

he population of the study consists of patients diagnosed with diabetes and undergoing surgery in the Surgical and Mixed service of Izzet Baysal Training and Research Hospital. The sample number of the experimental study, which was planned to be carried out between January 2025 and December 2026, was planned to include 100 patients with 0.05 error, 0.95 confidence interval and 0.85 power in the calculation made in the Gpower statistical programme based on previous studies. Considering that patients could leave the study for other reasons, it was decided to carry out the study by randomisation with 110 patients, which is 10% more.

Discharge Training Satisfaction Scale for Surgical Patients: It is a scale developed to measure the satisfaction of surgical patients with discharge training. It consists of 21 items in a five-point Likert structure and has been evaluated as a valid and reliable tool for measuring patient satisfaction. The scale covers factors such as discharge process, personal information, home care, infection monitoring and controls. The Cronbach α reliability coefficient was found to be 0.91, indicating that the scale is highly reliable Diabetes Empowerment Scale: It is a 5-point Likert-type scale consisting of 8 items. Turkish validity and reliability was carried out by Jahanpeyma et al. in 2020

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
110
Inclusion Criteria
  • He's had an operation,
  • Over 18 years old,
  • Diagnosed with diabetes,
  • Conscious patients returning to the clinic after surgery, not intubated
Exclusion Criteria
  • He's unconscious,
  • Referral to intensive care,
  • Patients who do not agree to participate in the study will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Satisfaction with Discharge Trainingthrough study completion, an average of 1 year

It will be measured with the Discharge Training Satisfaction Scale Specific to Surgical Patients.

Satisfaction will be measured with the 'Discharge Training Satisfaction Scale'. It consists of 21 items in a 5-point Likert scale. The scale does not contain negative items. The lowest score of 21 points and the highest score of 105 points can be obtained from the scale.

diabetes empowermentthrough study completion, an average of 1 year

The ability to manage the disease will be measured with the Diabetes Empowerment Scale.

There are 28 items in Diabetes Empowerment Scale. Five-point Likert type (1:

Strongly disagree, 5: Strongly agree), items 18,20,21,22,23,24,25,26 and 27 of this scale are under the sub-dimension of 'Self-awareness-managing psychological aspects of illness'; items 1,2,3,4,15,16,17 and 19 are under the sub-dimension of 'Ability to achieve goals'; items 5,6,7,8,9,10,11,12,13 and 14 are under the sub-dimension of 'Ability to set goals'.

The minimum score of the scale is 28 and the maximum score is 140. A score between 28-65 points indicates a low level of resilience, 66-103 indicates a medium level, and 104-140 indicates a high level of resilience.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Abant Izzet Baysal University Faculty of Health Science

🇹🇷

Bolu, Merkez, Turkey

© Copyright 2025. All Rights Reserved by MedPath